首页/数据集/Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC

Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC

NCATS Open Data2022-02-18 更新2026-08-08 收录

疫苗免疫原性

变异株疫苗有效性

数据链接：

https://doi.org/10.1101/2022.02.15.22270948 数据链接链接失效反馈

官方服务：

资源简介：

Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC

应用场景：

创建时间：

2022-02-15

疫苗免疫原性

临床试验生物标志物

1n/N: responders (n) as proportion of the (sub-)population (N). 2GMT: geometric mean titer; 395% CI: 95% confidence interval. 4Seroprotection rate: proportion of subjects with a protective titer pre-

NIAID Data Ecosystem40

Serum neutralizing antibody response induced by a single 103 PFU dose of rDEN1Δ30.

疫苗免疫原性

登革热抗体

1Plaque reduction neutralization titer 60%. Geometric mean titers calculated for all subjects who developed detectable antibody, including those who did not seroconvert (see footnote 3).2Infection is

Figshare2015-12-02 更新20

Immunogenic breadth of candidate vaccine viruses against 2013–2017 H7N9 strains.

疫苗免疫原性

禽流感病毒

Immunogenic breadth of candidate vaccine viruses against 2013–2017 H7N9 strains.

Figshare2020-12-23 更新10

ATN 024 Eligibility and Enrollment [CRF 1] Dataset in A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth

HIV阳性青少年乙肝疫苗接种

疫苗免疫原性

Data from Eligibility and Enrollment Form [CRF 1] Study Description Suboptimal response to hepatitis B vaccination in HIV-positive adults and children has been well documented in the literature. This

NIAID Data Ecosystem30

Significant Differences of WNV Antibody Levels.

疫苗免疫原性

西尼罗河病毒抗体检测

Means of Diffs. is the mean of the difference of all paired OD values, between reading taken prior to vaccination (day −1) and those taken on either day 16 or day 35 (as specified in Day column), for

Figshare2015-12-02 更新10

Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC

资源简介：

相关数据集